Daily Oncology News

The ESMO OncologyPRO news, provided in partnership with medwireNews, ensures that you're always kept up to date with the latest developments in the field of medical oncology. You can browse articles by date or by topic.

Browse archives for older articles from 2016, 2015, 2014 (all articles may be found in search)

Did you know how medwireNews writes our articles?

Filter

Date Title Topic
01 Oct 2017 Bevacizumab ‘Efficient And Well Tolerated’ For Elderly Metastatic CRC Patients Anti-Cancer Agents & Biologic Therapy - Geriatric Oncology - Colon Cancer - Rectal Cancer
21 Sep 2017 Metastatic CRC Response To Bevacizumab, Cetuximab Dictated By Primary Tumour Side Anti-Cancer Agents & Biologic Therapy - Colon Cancer - Rectal Cancer
31 Aug 2017 Avoidance Of Remnant Liver Ischaemia ‘Essential’ During Colorectal Cancer Metastases Resection Colon Cancer - Rectal Cancer - Surgery and/or Radiotherapy of Cancer
15 Aug 2017 Novel Early-Stage CRC Prognostic Features Uncovered Colon Cancer - Rectal Cancer
07 Aug 2017 SIRT Plus FOLFOX ‘Not Recommended’ Overall For Colorectal Cancer Liver Metastases Anti-Cancer Agents & Biologic Therapy - Colon Cancer - Rectal Cancer - Surgery and/or Radiotherapy of Cancer
03 Aug 2017 TAS-102 Plus Bevacizumab ‘Promising’ For Refractory Metastatic Colorectal Adenocarcinoma Anti-Cancer Agents & Biologic Therapy - Colon Cancer - Rectal Cancer
25 Jul 2017 Nivolumab Has ‘Encouraging Activity’ In dMMR/MSI-H Metastatic Colorectal Cancer Cancer Immunology and Immunotherapy - Colon Cancer - Rectal Cancer
21 Jun 2017 OS Equal For Cetuximab And Bevacizumab In Advanced KRAS Wild-Type CRC Anti-Cancer Agents & Biologic Therapy - Colon Cancer - Rectal Cancer
30 May 2017 FOLFOXIRI–Bevacizumab ORR Allows Secondary Resection For Metastatic CRC Anti-Cancer Agents & Biologic Therapy - Colon Cancer - Rectal Cancer
26 Apr 2017 Hepatic Arterial Infusion Chemotherapy OS Benefit Reported For CRC Liver Metastases Anti-Cancer Agents & Biologic Therapy - Colon Cancer - Rectal Cancer
21 Apr 2017 PD-L1 Levels Modify Aspirin Effect On CRC Survival Cancer Aetiology, Epidemiology, Prevention - Cancer Immunology and Immunotherapy - Colon Cancer - Rectal Cancer
10 Apr 2017 Hand–Foot Syndrome Incidence Lower With S-1 Than Capecitabine In Western mCRC Patients Anti-Cancer Agents & Biologic Therapy - Colon Cancer - Rectal Cancer